Why do people develop antibodies to food? While clinicians have long observed that healthy humans develop a particular type ...

This regulatory approval is the second for VYVGART SC in Europe, which first received approval as an add-on to standard therapy for the treatment of adult patients with generalized myasthenia gravis ...

Patients with small fiber neuropathy and cerebellar ataxia were more likely to have anti-gliadin antibodies when a lower test ...

Three dimensional immunohistochemistry (3D-IHC) has transformed our ability to visualize the spatial arrangement of cells and ...

A recent serosurvey in Tamil Nadu reveals 97% of elderly have Covid-19 antibodies. The report indicates widespread immunity.

In the Phase III VISIONARY study, sibeprenlimab, an investigational monoclonal antibody, showed a 51.2% reduction in ...

The FDA has approved Imaavy™ (nipocalimab-aahu) for the treatment of generalized myasthenia gravis in patients aged 12 years and older who are AChR or anti-muscle-specific tyrosine kinase antibody ...

Otsuka's investigational antibody sibeprenlimab approximately halved levels of this key biomarker in patients with ...

A new trial finds that intravenous immunoglobulin stabilises kidney function and slows damage in patients with chronic antibody-mediated rejection.

Here are seven things to know about the traveler with measles who recently spent time at Sky Harbor Airport in Phoenix ...